Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

by John Stagg, Bertrand Allard
Published 2013-05-01

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

by Bertrand Allard, Martin Turcotte, John Stagg
Published 2012-01-01

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis

by Bertrand Allard, Isabelle Cousineau, David Allard, Laurence Buisseret, Sandra Pommey, Pavel Chrobak, John Stagg
Published 2019-08-01

A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment

by Melanie Mediavilla-Varela, Julio Castro, Alberto Chiappori, David Noyes, Dalia C. Hernandez, Bertrand Allard, John Stagg, Scott J. Antonia
Published 2017-07-01

521 Immune regulatory metabolites in human ovarian cancer

by John Stagg, Bertrand Allard, Julian Lum, Marisa Kilgour, Sarah MacPherson, Lauren Zacharias, Sarah Keyes, Julian Smazynski, Peter Watson, Bradley Nelson, Ralph Deberardinis, Phineas Hamilton
Published 2020-11-01

WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors

by Pierre-Olivier Gaudreau, Sylvie Clairefond, Caleb A. Class, Pierre-Luc Boulay, Pavel Chrobak, Bertrand Allard, Feryel Azzi, Sandra Pommey, Kim-Anh Do, Fred Saad, Dominique Trudel, Marian Young, John Stagg
Published 2019-05-01